Alex Rubinsteyn on the 10 years of personalized cancer vaccine trials that went nowhere: sequence the cancer, build the vaccine, give it to the patient, then they die of cancer and you start another one "I switched from CS to biomedical research when personalized cancer vaccines were taking off. Once you could sequence DNA and RNA, people were like, why don't we just sequence everyone's tumors?" "ML models were being built to say, some of these mutations might be targetable by the adaptive…